Representative Dan Newhouse (R-Washington) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on May 16th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on April 11th. The trade occurred in the Representative's "EDWARD JONES IRA" account.
Representative Dan Newhouse also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Union Pacific NYSE: UNP on 4/11/2025.
- Sold $1,001 - $15,000 in shares of PayPal NASDAQ: PYPL on 4/11/2025.
- Sold $1,001 - $15,000 in shares of Moody's NYSE: MCO on 4/11/2025.
- Sold $1,001 - $15,000 in shares of NVIDIA NASDAQ: NVDA on 4/11/2025.
- Sold $1,001 - $15,000 in shares of Dollar General NYSE: DG on 4/11/2025.
- Sold $1,001 - $15,000 in shares of Lowe's Companies NYSE: LOW on 4/11/2025.
- Sold $1,001 - $15,000 in shares of Intuit NASDAQ: INTU on 4/11/2025.
- Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 4/11/2025.
- Sold $1,001 - $15,000 in shares of BlackRock NYSE: BLK on 4/11/2025.
- Sold $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 4/11/2025.
UnitedHealth Group Stock Performance
UnitedHealth Group stock traded down $0.74 during midday trading on Friday, reaching $295.93. 5,737,744 shares of the stock traded hands, compared to its average volume of 6,528,863. The firm has a fifty day moving average price of $456.57 and a two-hundred day moving average price of $506.94. The firm has a market cap of $268.45 billion, a price-to-earnings ratio of 19.10, a PEG ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the firm posted $6.91 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.84%. UnitedHealth Group's dividend payout ratio is currently 35.18%.
Analyst Ratings Changes
A number of equities research analysts have issued reports on UNH shares. Bank of America downgraded shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their target price for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a report on Monday. TD Securities reissued a "hold" rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday. KeyCorp lowered their target price on shares of UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Finally, Wall Street Zen upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus price target of $441.87.
Check Out Our Latest Report on UNH
Insiders Place Their Bets
In other UnitedHealth Group news, CFO John F. Rex acquired 17,175 shares of the company's stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director John H. Noseworthy bought 300 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the acquisition, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. The trade was a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock valued at $31,607,768 in the last 90 days. 0.33% of the stock is currently owned by insiders.
Hedge Funds Weigh In On UnitedHealth Group
Several institutional investors and hedge funds have recently made changes to their positions in the company. Norges Bank acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $6,375,744,000. GAMMA Investing LLC raised its position in UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Nuveen LLC acquired a new position in UnitedHealth Group during the 1st quarter worth approximately $3,846,764,000. Vanguard Group Inc. boosted its holdings in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $1,914,740,000. Institutional investors and hedge funds own 87.86% of the company's stock.
About Representative Newhouse
Dan Newhouse (Republican Party) is a member of the U.S. House, representing Washington's 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.
Newhouse (Republican Party) ran for re-election to the U.S. House to represent Washington's 4th Congressional District. He won in the general election on November 5, 2024.
Click here to see Newhouse's key votes in Congress.
Newhouse served as a member of the Washington House of Representatives representing District 15-Position 2 from 2003 through 2009 and as Washington Director of Agriculture from 2009 to 2013.
Newhouse was first elected to the state House in 2002 and served until he was named state Director of Agriculture in 2009. He was first appointed by Governor Christine Gregoire on February 18, 2009.
UnitedHealth Group Company Profile
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
